We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Parametr NEDA-3 z pohledu současné léčby roztroušené sklerózy.
- Authors
Pavelek, Zbyšek; Matyáš, David
- Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease which affects central nervous system. Initiation of the treatment early in the course of multiple sclerosis may postpone the disease progression and development of disability. One of the goals of MS treatment is a state without clinical and subclinical markers of disease activity, known as NEDA (No Evidence of Disease Activity). This work focuses on the concept of NEDA-3 with respect to the current treatment of MS.
- Subjects
CENTRAL nervous system; MULTIPLE sclerosis; BIOMARKERS; DISEASE progression; DISABILITIES; AUTOIMMUNE diseases
- Publication
Remedia, 2023, Vol 33, Issue 4, p313
- ISSN
0862-8947
- Publication type
Article